Cargando…
Association of Systemic Adverse Reactions and Serum SARS-CoV-2 Spike Protein Antibody Levels after Administration of BNT162b2 mRNA COVID-19 Vaccine
OBJECTIVES: The influential factors for anti-severe acute respiratory syndrome coronavirus 2 spike protein antibody (S-ab) levels were assessed after the administration of BNT162b2 mRNA coronavirus disease-2019 (COVID-19) vaccine at short and medium terms. METHODS: A total of 470 healthcare workers...
Autores principales: | Takahashi, Wataru, Mizuno, Toshiko, Hara, Kaori, Ara, Yoshiaki, Hurutani, Rikiya, Agatsuma, Toshihiko, Fujimori, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683821/ https://www.ncbi.nlm.nih.gov/pubmed/35989281 http://dx.doi.org/10.2169/internalmedicine.9699-22 |
Ejemplares similares
-
Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022) -
Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan
por: Kitagawa, Hiroki, et al.
Publicado: (2022) -
Blood Antibody Titers and Adverse Reactions after BNT162b2 mRNA Vaccination
por: Kiewisz, Jolanta, et al.
Publicado: (2022) -
Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination
por: Yasuda, Eriko, et al.
Publicado: (2022) -
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2023)